Radical prostatectomy versus observation for localized prostate cancer, N Engl J Med, vol.367, pp.203-216, 2012. ,
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer, N Engl J Med, vol.375, pp.1415-1439, 2016. ,
Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial, Eur Urol, vol.66, pp.243-50, 2014. ,
Prognostic role of Ki-67 score in localized prostate cancer: A systematic review and meta-analysis, Urol Oncol, vol.35, pp.499-506, 2017. ,
Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study, Br J Cancer, vol.100, pp.888-93, 2009. ,
Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort, Br J Cancer, vol.108, pp.271-278, 2013. ,
An update of the Gleason grading system, J Urol, vol.183, pp.433-473, 2010. ,
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score, Eur Urol, vol.69, pp.428-463, 2016. ,
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group, J Natl Cancer Inst, vol.103, pp.1656-64, 2011. ,
Quality assurance trials for Ki67 assessment in pathology, Virchows Arch: Int J Pathol, vol.471, pp.501-509, 2017. ,
Prognostic histopathological and molecular markers on prostate cancer needlebiopsies: a review, Biomed Res Int, p.341324, 2014. ,
Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study, Lancet Oncol, vol.12, pp.245-55, 2011. ,
Cell proliferation assessed by Ki-67 immunoreactivity on formalin fixed tissues is a predictive factor for survival in prostate cancer, J Urol, vol.157, pp.219-241, 1997. ,
Ki-67 staining index predicts distant metastasis and survival in locally advanced prostate cancer treated with radiotherapy: an analysis of patients in radiation therapy oncology group protocol 86-10, Clin Cancer Res, vol.10, pp.4118-4142, 2004. ,
Ki-67 staining is a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial 92-02, J Clin Oncol, vol.22, pp.2133-2173, 2004. ,
MDM2 and Ki-67 predict for distant metastasis and mortality in men treated with radiotherapy and androgen deprivation for prostate cancer: RTOG 92-02, J Clin Oncol, vol.27, pp.3177-84, 2009. ,
Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model, Mayo Clin Proc, vol.89, pp.308-326, 2014. ,
Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies, Prostate Cancer Prostatic Dis, vol.19, pp.264-70, 2016. ,
High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer, Urol Oncol, vol.36, pp.161-168, 2018. ,
KI67 and DLX2 predict increased risk of metastasis formation in prostate cancer-a targeted molecular approach, Br J Cancer, vol.115, pp.236-278, 2016. ,
Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System, International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of, vol.40, pp.244-52, 2014. ,
Influence of intra-tumoral heterogeneity on the evaluation of BCL2, Ecadherin, EGFR, EMMPRIN, and Ki-67 expression in tissue microarrays from breast cancer, Acta Oncol, vol.57, pp.102-108, 2018. ,
Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification, Am J Surg Pathol, vol.35, pp.853-60, 2011. ,
Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy, World J Urol, 2018. ,
Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position, Eur Urol, vol.74, pp.357-68, 2018. ,
Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort, PLoS ONE, vol.12, p.186852, 2017. ,